These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3994071)

  • 1. Predisposing factors to apparent theophylline-induced seizures.
    Covelli HD; Knodel AR; Heppner BT
    Ann Allergy; 1985 May; 54(5):411-5. PubMed ID: 3994071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical review on patients who developed seizures during theophylline administration: relationships with seizure-predisposing factors].
    Odajima Y; Nakano H; Kato T
    Arerugi; 2006 Oct; 55(10):1295-303. PubMed ID: 17072109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous furosemide on serum theophylline concentration.
    Conlon PF; Grambau GR; Johnson CE; Weg JG
    Am J Hosp Pharm; 1981 Sep; 38(9):1345-7. PubMed ID: 7282719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures during concomitant treatment with theophylline and ranitidine: a case report.
    Murialdo G; Piovano PL; Costelli P; Fonzi S; Barberis A; Ghia M
    Ann Ital Med Int; 1990; 5(4 Pt 1):413. PubMed ID: 2093363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theophylline toxicity in a patient with status asthmaticus].
    Saitoh Y; Bando T; Kanamori K; Mifune J; Sasaki F; Ishizaki T; Miyabo S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30(12):2118-22. PubMed ID: 1289633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline-induced seizures: clinical and pathophysiologic aspects.
    Nakada T; Kwee IL; Lerner AM; Remler MP
    West J Med; 1983 Mar; 138(3):371-4. PubMed ID: 6858124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine-theophylline interaction: report of four patients.
    Bauman JH; Kimelblatt BJ; Caraccio TR; Silverman HM; Simon GI; Beck GJ
    Ann Allergy; 1982 Feb; 48(2):100-2. PubMed ID: 6121526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
    Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical review of patients with convulsions during theophylline administration II: points to consider in administration and prognosis as determined in patients with theophyline toxicosis].
    Odajima Y; Okada K; Kato T; Nakano H
    Arerugi; 2007 Jul; 56(7):691-8. PubMed ID: 17671412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor symptoms are not predictive of elevated theophylline levels in adults on chronic therapy.
    Melamed J; Beaucher WN
    Ann Allergy Asthma Immunol; 1995 Dec; 75(6 Pt 1):516-20. PubMed ID: 8603282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild theophylline-related adverse reactions and serum theophylline concentration.
    Barr JT; Schumacher GE; Luks DB; Karpel J
    Am J Hosp Pharm; 1994 Nov; 51(21):2688-92. PubMed ID: 7856581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroconvulsive therapy in patients taking theophylline.
    Rasmussen KG; Zorumski CF
    J Clin Psychiatry; 1993 Nov; 54(11):427-31. PubMed ID: 8270586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes.
    Hoh BL; Chapman PH; Loeffler JS; Carter BS; Ogilvy CS
    Neurosurgery; 2002 Aug; 51(2):303-9; discussion 309-11. PubMed ID: 12182768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of theophylline on sleep-disordered breathing in patients with stable chronic congestive heart failure.
    Hu K; Li Q; Yang J; Hu S; Chen X
    Chin Med J (Engl); 2003 Nov; 116(11):1711-6. PubMed ID: 14642143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL; Maddux MS; Organek HW; Bauman JL
    Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.